MedTechnology
ByWill Tempus AI’s FDA Clearance Redefine the Future of Cardiac Imaging?
Key Highlights: Tempus AI Secures FDA Clearance for Tempus Pixel Tempus AI announced that its advanced imaging platform,…
Will GE HealthCare’s Acquisition of icometrix Redefine AI-Powered Neurology Imaging?
Chicago – GE HealthCare (Nasdaq: GEHC) announced it has entered into a definitive agreement to acquire icometrix, a…
Can BD’s Expanded Recall of Alaris™ Pump Infusion Sets Trigger a Turning Point in Medical Device Safety Standards?
Key Insights BD’s updated recall follows internal testing that revealed infusion performance deviations, including flow rate accuracy issues,…
Can Johnson & Johnson’s Pact with Pacira BioSciences Redefine Early Intervention for Knee Osteoarthritis?
Key Insights Expanding Non-Surgical Pathways Through this agreement, Johnson & Johnson MedTech integrates ZILRETTA® into its Early Intervention…
Will Johnson & Johnson’s FDA Approval of INLEXZO™ Redefine Bladder Cancer Care After 40 Years of Limited Progress?
Key Highlights: A Breakthrough in Bladder Cancer TreatmentThe U.S. FDA has approved INLEXZO™ (gemcitabine intravesical system), marking the…
Could GE HealthCare’s FDA-Cleared Revolution™ Vibe CT System Usher in a New Era of AI-Powered Cardiac Imaging?
Key Highlights Revolutionizing Cardiac Imaging with One-Beat ClarityGE HealthCare’s Revolution Vibe CT system has received U.S. FDA 510(k)…
